BOUT Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF

USD 35.77 0.04 0.108884
Icon

Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF (BOUT) Stock Analysis and Price Targets

ETF | Mid-Cap Growth | NYE
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 35.77

+0.04 (+0.11)%

USD 0.01B

301.00

N/A

N/A

Icon

BOUT

Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF (USD)
ETF | NYE
USD 35.77
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.01B

N/A

USD 35.77

Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF (BOUT) Stock Forecast

N/A

Based on the Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF stock forecast from 0 analysts, the average analyst target price for Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF is not available over the next 12 months. Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF is Slightly Bearish, which is based on 2 positive signals and 4 negative signals. At the last closing, Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF’s stock price was USD 35.77. Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF’s stock price has changed by +2.69% over the past week, +9.48% over the past month and +19.40% over the last year.

No recent analyst target price found for Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF
No recent average analyst rating found for Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF

Company Overview Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF

The fund normally invests at least 80% of its net assets (including borrowings for investment purposes) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to break out, or experience a ...Read More

N/A

N/A

N/A

N/A

USD

USA

12/09/2018

IBD Breakout Stocks TR USD

N/A

0.85 %

Adjusted Closing Price for Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF (BOUT)

Loading...

Unadjusted Closing Price for Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF (BOUT)

Loading...

Share Trading Volume for Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF Shares

Loading...

Compare Performance of Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BOUT

Top Sectors

N/A

Top Regions

N/A

Valuation Growth & Performance

  • 4

  • N/A

  • N/A

  • 20.21

  • 0.00

  • -0.05

  • 5.22%

  • 1.96%

  • 11.61%

  • 0%

Stocks Similar To Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF (Sector: Mid-Cap Growth )

Symbol Name Mer Price(Change) Market Cap
IWP
iShares Russell Mid-Cap Growth.. 0.23 % -0.48 (-0.43%) USD14.27B

ETFs Containing BOUT

Symbol Name BOUT's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF (BOUT) Stock

Stock Target Advisor's fundamental analysis for Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF's stock is Slightly Bearish.

BOUT stock's dividend yield is 1.30%. Our analysis grades BOUT stock's dividend yield at B-. This means that BOUT stock's dividend yield is above 80% of the stocks in the Mid-Cap Growth sector in the NYE exchange. Based on this BOUT may be a good dividend stock for its sector.

Unfortunately we do not have enough data on BOUT's stock to indicate what its average analyst target is.

BOUT stock's Price/Earning ratio is 25.90. Our analysis grades BOUT stock's Price / Earning ratio at F. This means that BOUT stock's Price/Earning ratio is above 75% of the stocks in the Mid-Cap Growth sector in the NYE exchange. Based on this BOUT may be a overvalued for its sector.

The last closing price of BOUT's stock was USD 35.77.

The most recent market capitalization for BOUT is USD 0.01B.

Unfortunately we do not have enough analyst data on BOUT's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF's stock.

Sorry, we do not have any data on the number of employees for Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF.

Sorry we do not have any infomation available on Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF's address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...